PTPN11 and prostate cancer: Furthermore, by weakening the PAR3/PAR6/aPKC polar protein complex as well as promoting EMT, SHP2 can encourage the migration of prostate tumor cells both in vivo and in vitro, as well as the spread of prostate cancer (144).